INOTEK PHARMACEUTICALS CORP's ticker is and the CUSIP is 45780VAB8. A total of 9 filers reported holding INOTEK PHARMACEUTICALS CORP in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,108,000 | -70.8% | 1,000,000 | -73.3% | 0.08% | -70.9% |
| Q2 2018 | $3,796,000 | -20.7% | 3,750,000 | -25.0% | 0.26% | -29.9% |
| Q1 2018 | $4,785,000 | -31.8% | 5,000,000 | -42.9% | 0.38% | -16.4% |
| Q4 2017 | $7,016,000 | -7.3% | 8,750,000 | -9.8% | 0.45% | -8.3% |
| Q3 2017 | $7,572,000 | +30.9% | 9,700,000 | 0.0% | 0.49% | +24.8% |
| Q2 2017 | $5,784,000 | +1.1% | 9,700,000 | 0.0% | 0.40% | +25.8% |
| Q1 2017 | $5,723,000 | -3.5% | 9,700,000 | +70.2% | 0.31% | +9.4% |
| Q4 2016 | $5,928,000 | -22.7% | 5,700,000 | 0.0% | 0.29% | -18.5% |
| Q3 2016 | $7,670,000 | – | 5,700,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 7,700,000 | $6,036,000 | 0.92% |
| Telemetry Investments, L.L.C. | 1,750,000 | $1,403,000 | 0.54% |
| Springhouse Capital Management, LP | 1,300,000 | $988,000 | 0.48% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 8,750,000 | $7,016,000 | 0.45% |
| Bruce & Co., Inc. | 2,000,000 | $1,600,000 | 0.35% |
| DAFNA Capital Management LLC | 600,000 | $452,000 | 0.24% |
| Orbimed Advisors | 7,000,000 | $5,918,000 | 0.08% |
| Baker Brothers Advisors | 5,000,000 | $4,009,000 | 0.04% |
| Citadel Advisors | 7,500,000 | $5,700,000 | 0.00% |